Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/4/2022 | $4.00 | Buy | Needham |
Needham initiated coverage of Fast Radius with a rating of Buy and set a new price target of $4.00
CHICAGO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Fast Radius, Inc. ("Fast Radius") (NASDAQ:FSRD), a cloud manufacturing and digital supply chain company, reported financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Financial Summary Revenue increased 49% to $7.3 million in second quarter 2022 compared to $4.9 million in second quarter 2021;Net loss was $22.2 million in second quarter 2022, or $0.29 per diluted share, compared to a net loss of $15.1 million, or $0.36 per diluted share, in second quarter 2021;Adjusted EBITDA loss was $17.3 million in second quarter 2022 compared to a loss of $13.5 million in second quarter 2021; andTotal Bookings were $7 million in
CHICAGO, July 28, 2022 (GLOBE NEWSWIRE) -- Fast Radius, Inc. (NASDAQ:FSRD), a cloud manufacturing and digital supply chain company, will hold a conference call on Thursday, August 11 at 9:00 a.m. Eastern Time (8:00 a.m. Central Time) to discuss its financial results for the second quarter ended June 30, 2022. Financial results will be issued in a press release prior to the call. Fast Radius management will host the presentation, followed by a question-and-answer period. Conference Call Details:Date: Thursday, August 11, 2022Time: 9:00 a.m. ET / 8:00 a.m. CTWebcast Event: LinkToll-Free Dial-in Number: (800) 715-9871International Dial-in Number: (646) 307-1963Conference ID: 5146031 The c
CHICAGO, May 12, 2022 (GLOBE NEWSWIRE) -- Fast Radius, Inc. ("Fast Radius") (NASDAQ:FSRD), a cloud manufacturing and digital supply chain company, reported financial results for the first quarter ended March 31, 2022. First Quarter 2022 Financial Summary Revenue increased 65% to $6.3 million in 2022 compared to $3.8 million in first quarter 2021;Total Bookings were $7 million in 2022, an increase of 36% compared to first quarter 2021;Net loss was $44.6 million in 2022, or $0.73 per diluted share, compared to a net loss of $12.8 million, or $0.33 per diluted share, in first quarter 2021; andAdjusted EBITDA loss was $21.2 million in 2022 compared to a loss of $8.2 million in first qua
SC 13G/A - Fast Radius, Inc. (0001832351) (Subject)
SC 13G/A - Fast Radius, Inc. (0001832351) (Subject)
SC 13G - Fast Radius, Inc. (0001832351) (Subject)
25-NSE - Fast Radius, Inc. (0001832351) (Subject)
8-K - Fast Radius, Inc. (0001832351) (Filer)
EFFECT - Fast Radius, Inc. (0001832351) (Filer)
CHICAGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Fast Radius, Inc. (NASDAQ:FSRD) ("Fast Radius'' or the "Company") received approval today from the United States Bankruptcy Court for the District of Delaware for its proposed sale and marketing procedures, including a bid deadline of December 5, 2022. The Company is in active discussions with one or more potential partners and continues to explore and evaluate strategic alternatives, including from newly interested parties. "We are pleased to have received approval of the bid procedures. This allows us to finish marketing our business and our first-of-its-kind Cloud Manufacturing Platform on an expedited timeline while continuing to serve our
CHICAGO, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Fast Radius, Inc. (NASDAQ:FSRD) ("Fast Radius'' or the "Company") announced today that the United States Bankruptcy Court for the District of Delaware has approved all of the first-day motions related to the Company's voluntary Chapter 11 petitions filed on November 7, 2022. The ruling enables Fast Radius to continue operations in the normal course including: Maintaining employee payroll and health benefits,Paying vendors for all post-petition goods and services,Continuing all customer programs, andOther programs that are essential to continuing the business without disruptions. In addition, the court set a hearing for Monday, November 14, to co
CHICAGO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Fast Radius, Inc. (NASDAQ:FSRD) ("Fast Radius'' or the "Company") announced today that it is launching an in-court process to effectuate one or more strategic transactions and has filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code in the District of Delaware. The Company has requested that the court establish certain sale and marketing procedures, which include a proposed bid deadline of December 5, 2022. The Company is in active discussions with one or more potential partners and continues to explore and evaluate strategic alternatives. "Fast Radius has invested over $200 million creating a first-of-its-k
4 - Fast Radius, Inc. (0001832351) (Issuer)
4 - Fast Radius, Inc. (0001832351) (Issuer)
4 - Fast Radius, Inc. (0001832351) (Issuer)
CHICAGO, June 14, 2022 (GLOBE NEWSWIRE) -- Fast Radius (NASDAQ:FSRD), a digital manufacturing and supply chain company, today announced the appointment of Pat McCusker as President and Interim Chief Financial Officer and John Nanry as Chief Operating Officer, effective June 30, 2022. McCusker and Nanry are both co-founders of Fast Radius. Over the past five years, McCusker has been instrumental in Fast Radius' growth, having held leadership roles across commercial execution, financial operations, capital markets engagement, and other functions. McCusker previously served as Interim CFO for Fast Radius from 2017 to August 2021. In this role, he led broad cross-functional teams to prepare f
CHICAGO, March 15, 2022 (GLOBE NEWSWIRE) -- Fast Radius, Inc. (NASDAQ:FSRD), a cloud manufacturing company, today announced it has named Erin Stone as General Counsel and Corporate Secretary, and James Erkenswick as Chief Accounting Officer. These leadership additions mark important milestones for Fast Radius' evolution as a publicly traded company. In her capacity as General Counsel and Corporate Secretary, Stone will serve as an important strategic and legal advisor to Fast Radius's board of directors and management and will oversee all legal and compliance matters for the company. In his role as Chief Accounting Officer, Erkenswick will have leadership over the preparation of all financ
Gainers Array Technologies (NASDAQ:ARRY) shares moved upwards by 17.0% to $19.87 during Tuesday's after-market session. Trading volume for this security closed at 259.9K, accounting for 6.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.9 billion. The company's, Q3 earnings came out today. Recruiter.Com Group (NASDAQ:RCRT) shares moved upwards by 17.01% to $0.68. The company's market cap stands at $11.0 million. Axon Enterprise (NASDAQ:AXON) stock moved upwards by 8.11% to $162.17. The market value of their outstanding shares is at $11.5 billion. The company's, Q3 earnings came out today. Fuel Tech (NASDAQ:FTEK) stock rose
Gainers Satixfy Communications Ltd. (NYSE:SATX) jumped 96.4% to settle at $51.70 on Thursday. Elevate Credit, Inc. (NYSE:ELVT) shares jumped 68.9% to close at $1.79 on Thursday after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67 million. Ardelyx Inc (NASDAQ:ARDX) shares climbed 41% to close at $1.72 as the company said the FDA Advisory Committee voted 9-To-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis. CytomX Therapeutics, Inc. (NASDAQ:CTMX) gained 32.2% to close at $1.60 after the company and Regeneron announced a s
Gainers Elevate Credit, Inc. (NYSE:ELVT) shares surged 71.2% to $1.8150 after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67 million. Ardelyx Inc (NASDAQ:ARDX) shares jumped 45.1% to $1.7699 as the company said the FDA Advisory Committee voted 9-To-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis. Satixfy Communications Ltd. (NYSE:SATX) gained 37.3% to $36.14. Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) surged 37.2% to $3.57. CytomX Therapeutics, Inc. (NASDAQ:CTMX) jumped 24.8% to $1.5110 after the company and Reg